Dow Up 0.76% Nasdaq Up 0.69%

ChemoCentryx, Inc. (CCXI)

-NasdaqGS
5.72 Down 0.23(3.87%) Oct 24, 3:59PM EDT
Prev Close:5.95
Open:5.95
Bid:5.26 x 900
Ask:6.15 x 100
1y Target Est:6.50
Beta:1.18
Next Earnings Date: 5-Nov-14CCXI Earnings announcement
Day's Range:5.63 - 5.98
52wk Range:4.09 - 8.25
Volume:68,362
Avg Vol (3m):83,165
Market Cap:247.88M
P/E (ttm):N/A
EPS (ttm):-1.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CCXI

Comparison

Symbol% ChgMkt Cap
CCXIDown 3.87%247.88M
ABTUp 0.07%63.85B
AMGNUp 0.01%111.86B
AZNUp 1.11%88.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):114.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.14
Quarterly EPS Est (Sep-14) :-0.28
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback